Key Takeaways
- • UC Davis launched the Aggie Venture Accelerator (AVA) in partnership with The March Group, a thematic venture capital firm, to support early-stage life science startups across food, health, and agriculture innovation sectors.
- • The inaugural cohort selected three startups: SinewUS (tendon-specific health platform), Pharm to Food (advanced analytical tools for product development), and ThriveSpan Labs (personalized metabolic wellness diagnostics for GLP-1 users).
- • Selected startups receive $250,000 in funding through the Aggie Venture Accelerator Fund, intensive mentorship, structured entrepreneurial training, strategic guidance, and industry connections to advance commercialization.
- • AVA plans 30 startup investments across its lifecycle, positioning the program as a significant accelerator for life science commercialization in Sacramento and broader California innovation ecosystem.
- • The program prioritizes early-stage companies at pre-seed to seed funding stages with strong founding teams seeking to solve complex problems at the nexus of food and health innovation.
Summary
The University of California, Davis Innovation and Economic Development Office announced the inaugural cohort of the Aggie Venture Accelerator (AVA), marking a strategic expansion of UC Davis' commercialization infrastructure. Delivered in partnership with The March Group, a thematic venture capital firm focused on food and health innovation, the accelerator represents UC Davis' commitment to bridging the gap between scientific discovery and market-ready ventures.
The program selected three founding companies through a competitive application process: SinewUS, which has developed a tendon-specific health platform; Pharm to Food, offering advanced analytical tools that provide actionable insights for product development; and ThriveSpan Labs, which provides personalized diagnostics supporting metabolic wellness for GLP-1 users. According to UC Davis leadership, these inaugural selections reflect the diversity of research being translated into commercial ventures at the institution.
Each selected startup receives $250,000 in funding through the dedicated Aggie Venture Accelerator Fund, complemented by intensive mentorship, structured entrepreneurial training, strategic guidance, and industry connections. The accelerator is based at Aggie Square in Sacramento and targets early-stage founders seeking pre-seed to seed funding with strong founding team credentials. The program plans to deploy capital across 30 startup investments over its lifecycle, indicating a substantial commitment to life science commercialization.
George Baxter, UC Davis' chief innovation and economic development officer, characterized the launch as "a transformative moment" for the university, emphasizing AVA's role in accelerating innovations that "protect and nourish the lives of Californians and people around the world." The program's focus on the intersection of food and health addresses urgent market demand, particularly as consumer interest in personalized health solutions and sustainable food innovation continues to accelerate. By combining UC Davis' research infrastructure with The March Group's venture expertise and industry networks, AVA positions the university as a meaningful player in the life science startup ecosystem.
The program selected three founding companies through a competitive application process: SinewUS, which has developed a tendon-specific health platform; Pharm to Food, offering advanced analytical tools that provide actionable insights for product development; and ThriveSpan Labs, which provides personalized diagnostics supporting metabolic wellness for GLP-1 users. According to UC Davis leadership, these inaugural selections reflect the diversity of research being translated into commercial ventures at the institution.
Each selected startup receives $250,000 in funding through the dedicated Aggie Venture Accelerator Fund, complemented by intensive mentorship, structured entrepreneurial training, strategic guidance, and industry connections. The accelerator is based at Aggie Square in Sacramento and targets early-stage founders seeking pre-seed to seed funding with strong founding team credentials. The program plans to deploy capital across 30 startup investments over its lifecycle, indicating a substantial commitment to life science commercialization.
George Baxter, UC Davis' chief innovation and economic development officer, characterized the launch as "a transformative moment" for the university, emphasizing AVA's role in accelerating innovations that "protect and nourish the lives of Californians and people around the world." The program's focus on the intersection of food and health addresses urgent market demand, particularly as consumer interest in personalized health solutions and sustainable food innovation continues to accelerate. By combining UC Davis' research infrastructure with The March Group's venture expertise and industry networks, AVA positions the university as a meaningful player in the life science startup ecosystem.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.